| payload |
{"created_at":"2026-04-07T03:18:43.308 {"created_at":"2026-04-07T03:18:43.308311+00:00","dedupe_key":"signal_enriched:discovery_sec_filing_delta:f6962788ffe1993d","evidence_event_ids":["evt_7c76b6e02576"],"signal_type":"discovery_sec_filing_delta","source":"discovery_sec_filings","value":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1630627/0001630627-26-000005.txt","as_of":"2026-04-07T03:18:43.308311+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1630627/0001630627-26-000005.txt","company":"TREACE MEDICAL CONCEPTS, INC.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1630627/0001630627-26-000005.txt","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_a88f993065c483ff","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1630627/0001630627-26-000005.txt","content_type":"text/plain","enriched_at":"2026-04-07T08:22:46.606571+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"DEF 14A","final_url":"https://www.sec.gov/Archives/edgar/data/1630627/0001630627-26-000005.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1630627/0001630627-26-000005.txt","source_event_id":"evt_7c76b6e02576","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"DEF 14A","fp":"98aa9ec5291376e8","kind":"sec_filing","published_at":"20260406","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":1.0,"dates_mentioned":["2026-04-06","2026-05-19"],"entities":[{"asset_class":"equity","name":"Treace Medical Concepts, Inc.","relevance":"high","symbol":"TMCI","type":"issuer"}],"event_type":"listing","information_gaps":["No specific changes from prior filings mentioned","Details on financial implications not provided"],"key_facts":["DEF 14A filed on April 6, 2026","Annual Meeting scheduled for May 19, 2026","Focus on bunion treatment innovations"],"numeric_claims":[],"primary_claim":"Treace Medical Concepts, Inc. filed a DEF 14A on April 6, 2026.","relevance_score":0.8,"sentiment":"neutral","source_quality":"high","summary":"Treace Medical Concepts, Inc. filed a DEF 14A proxy statement on April 6, 2026, detailing the upcoming Annual Meeting and key accomplishments in addressing bunion treatments.","topics":["SEC Filing","Proxy Statement","Annual Meeting"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form DEF 14A \u00b7 TREACE MEDICAL CONCEPTS, INC. \u00b7 Filed 20260406","ticker":"TMCI","tickers":["TMCI"],"title":"TMCI filed DEF 14A","url":"https://www.sec.gov/Archives/edgar/data/1630627/0001630627-26-000005.txt"}}... |